A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice Severe ADR to bDMARDS in elderly RA /L. Leon et al
2018
Clinical and Experimental Rheumatology
unpublished
Objective Biological DMARDs are widely used in the treatment of rheumatoid arthritis (RA) but their relationship with adverse drug reaction (ADR) is important. RA is now known to increase in incidence and prevalence with age. Our objective was to assess the incidence of severe ADR in the long term, compare safety between the different bDMARDs and identify other possible risk factors for severe ADR in elderly RA patients. Methods A 14-year retrospective longitudinal study was performed. RA
fatcat:n3h33d3t4ngnrnzrpobco6nnrm